SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000906709-23-000004
Filing Date
2023-02-28
Accepted
2023-02-28 16:48:43
Documents
93
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nktr-20221231.htm   iXBRL 10-K 2149347
2 EX-21.1 nktr20221231-exx211.htm EX-21.1 1351
3 EX-23.1 nktr20221231-exx231.htm EX-23.1 5822
4 EX-31.1 nktr-20221231xexx311.htm EX-31.1 8113
5 EX-31.2 nktr-20221231xexx312.htm EX-31.2 8116
6 EX-32.1 nktr-20221231xexx321.htm EX-32.1 6349
12 nktr-20221231_g1.jpg GRAPHIC 308646
  Complete submission text file 0000906709-23-000004.txt   10496423

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20221231.xsd EX-101.SCH 77602
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20221231_cal.xml EX-101.CAL 108062
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20221231_def.xml EX-101.DEF 322885
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20221231_lab.xml EX-101.LAB 847302
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20221231_pre.xml EX-101.PRE 553216
87 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20221231_htm.xml XML 1548372
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 23686584
SIC: 2834 Pharmaceutical Preparations